Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.
about
Phenotype standardization for statin-induced myotoxicityEfficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale.Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese population.Anti-HMGCR antibodies in systemic sclerosisRisk of disseminated intravascular coagulation in patients with type 2 diabetes mellitus: retrospective cohort study.Incidence of venous thromboembolism and bleeding events in patients with lower extremity orthopedic surgery: a retrospective analysis of a Japanese healthcare database.Excessive range of statin dose in Western Australian primary care.Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?Associations of Polyethylenimine-Coated AN69ST Membrane in Continuous Renal Replacement Therapy with the Intensive Care Outcomes: Observations from a Claims Database from Japan.Development and validation of algorithms for the detection of statin myopathy signals from electronic medical records.Common statin side effects explain poor compliance.Clinical and economic burdens experienced by patients with painful diabetic peripheral neuropathy: An observational study using a Japanese claims database.Transcatheter valve-in-ring implantation of a repositionable valve system for treatment of severe mitral regurgitation.Statin-associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany.
P2860
Q27020935-0823C4BE-3536-42B0-8477-CC6DE98247DFQ33808620-E89677E3-AEA7-45AE-BEBE-A5FC98C415A1Q34571112-EC126618-3E24-4679-8F47-53D914B65991Q36050960-C942CD22-280D-49DA-82E4-02200ABEBF7BQ36196309-43ED0245-2232-43AB-A8BE-9C36F8B898C1Q37612236-4CAD8444-03D6-4F61-A892-073159F5CFA3Q37737957-B25E6A03-1E25-46D2-8039-9FE55C2A6678Q38420257-419FA465-4393-4558-8F13-564BE76A1A57Q38541878-798D7FC3-7CA6-46F7-9E10-A9BBF01C21F9Q38975214-7C98A69F-55CA-40B7-BADB-6C313401F4A1Q39319994-21DCB025-F6FB-466B-9E77-F577F3F630FBQ42332407-3874F646-4C4F-47F0-869A-07EE460865C3Q47139356-7DB16518-0F72-42BA-95BF-D4719971A2F8Q50948677-70FF6C6F-D76A-47C5-80AA-4A87A6B26D47Q55129505-2C8D6C4B-4A44-4B25-9C5C-74EB9DE78FC0
P2860
Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Assessment of statin-associate ...... se and laboratory information.
@ast
Assessment of statin-associate ...... se and laboratory information.
@en
type
label
Assessment of statin-associate ...... se and laboratory information.
@ast
Assessment of statin-associate ...... se and laboratory information.
@en
prefLabel
Assessment of statin-associate ...... se and laboratory information.
@ast
Assessment of statin-associate ...... se and laboratory information.
@en
P2093
P2860
P1433
P1476
Assessment of statin-associate ...... se and laboratory information.
@en
P2093
Chia-Hsien Chang
Makiko Kusama
Manabu Akazawa
Shunsuke Ono
Takao Orii
Yuichi Sugiyama
P2860
P356
10.1136/BMJOPEN-2012-002040
P577
2013-04-11T00:00:00Z